Sign up online today & collaborate
or click here to find out more
The group at Manchester, led by Professor Tony Whetton, Professor of Cancer Cell Biology and Director of the Stoller Biomarker Discovery Centre and the Manchester Precision Medicine Institute, plus Dr Phil Crosbie, Consultant in Respiratory Medicine at the Northwest Lung Centre and senior clinical lecturer at The University of Manchester, will utilise longitudinal pre-diagnosis serum samples from the UKCTOCS biobank to find markers that elevate early, before clinical presentation with symptoms.
Lung cancer is the UK’s leading cancer killer, with nearly 35,000 people dying each year from the disease. Of the 44,500 people diagnosed with lung cancer in the UK each year, only half will still be alive after six months. However, when diagnosed at its earliest stages, up to 73% of non-small cell lung cancer patients will survive for five years or more.
For more click here
Source: University of Manchester